
Proactive Management
Testing the tick immediately informs treatment plans before symptoms become chronic or severe.
LymeAlert was founded by experienced medical professionals and scientists. They created LymeAlert in response to the question Erin often received from patients asking, “What should I do with the tick?”
Erin Dawicki CEO and Co-founder
LymeAlert began at MIT, where three Sloan Fellows MBA ’24 classmates developed the idea through the Institute’s healthcare entrepreneurship ecosystem.


Current diagnostic tools often miss more than 60% of early-stage Lyme cases
Multiple studies have shown that earlier access to antibiotics yields higher successful treatment rates.
The CDC currently recommends prophylactic antibiotics within 72 hours of removing an embedded and engorged tick in high-risk areas. (Learn more here).
Ticks are expanding into regions where they have not been prevalent before.
LymeAlert is designed to complement your clinical expertise by empowering patients to prioritize follow-up care.
OUR APPROACH
To become the world’s leading platform for early detection, intelligence, and response to vector-borne disease—starting with Lyme and expanding wherever risk emerges.

Testing the tick immediately informs treatment plans before symptoms become chronic or severe.

The test leverages immunoassay technology with lab-level accuracy.

Empower patients to take action and contact a healthcare professional instead of a “wait-and-see” approach.

Validated for use on ticks removed from people, pets, horses, and livestock.

Know if the tick carries Borrelia burgdorferi, allowing for targeted antibiotic treatment rather than prophylactic treatment.

The test uses a patent-pending molecular assay that is highly sensitive to Borrelia burgdorferi, even in small quantities.

The proprietary Tick Crusher™ exposes the pathogen from the tick’s midgut and salivary glands, allowing unmatched accuracy.

Knowing the specific exposure allows you to observe clinical signs with higher sensitivity and time subsequent blood tests in the window that they’re most likely to be accurate.
Built on science, designed for early detection.
LymeAlert is built using lab-based detection principles to detect the pathogen that can cause Lyme disease in ticks. By focusing on early-stage exposure and testing the tick, it provides answers in minutes instead of days, helping people make faster, more informed decisions.







Questions and answers
The LymeAlert test is intended as an early decision-making guide for individuals who have found a tick on a person or animal.
The test kit works on partial ticks as well as full ticks.
The test is not required to be FDA-approved as it tests the tick and is not a diagnostic tool.
At this time, the test only detects the presence of Borrelia Burgdorferi. Our team is working on being able to detect coinfections in the lab.
While it can identify if a tick is a carrier, a positive result from the tick does not confirm transmission to the host, nor does a negative result rule out infection from a different, unobserved tick bite.
Contact us for professional pricing to keep on hand for immediate client needs.
The kit can test both live and dead ticks and is intended for use with ticks found on humans or animals.